National Cancer Center Hospital — Chuo-ku, Tokyo

Public research footprint of National Cancer Center Hospital, compiled from the ClinicalTrials.gov public registry.

301

Registered studies

153

Active

Recruiting now

102

Completed

Stopped or withdrawn

Most-studied conditions

Metastatic or Locally Advanced Solid Tumors With Microsatellite… · Metastatic Non-Small-Cell Lung Cancer · Locally Advanced Unresectable Gastroesophageal Junction (GEJ)… · Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer

Recently updated registry entries

NCT06330064 — A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects… (Recruiting)
NCT07699939 — Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and… (Recruiting)
NCT05753501 — Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at National Cancer Center Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.